NCT03856710

Brief Summary

Inguinal (groin) hernias are common and occur when an internal part of the body pushes through a weakness in the surrounding tissue wall of the groin. They are more likely to occur in men and affect people's quality of life by causing pain that is worse after any strenuous activity. If untreated they can cause serious problems such as strangulation when too much bowel comes through the weakness and becomes squeezed with the risk of losing blood supply requiring emergency surgery. To prevent such complications, elective surgery for symptomatic inguinal hernias is undertaken either in the conventional open method which involves a cut in the groin, or the keyhole surgery, when the surgery is undertaken via three small incisions in the abdomen (instead of a single, larger groin incision), a thin tube containing a light source and a camera (laparoscope) is inserted through one of these incisions, so the surgeon can see inside the abdomen. Special surgical instruments are inserted through the other incisions, so the surgeon can pull or push the hernia back into place and a piece of mesh is then stapled or glued to secure it to the weakened area in the abdomen wall. Securing the mesh with staple has been associated with increased post-operative pain and analgesia requirement; whereas not doing so has been thought to increase the chances of recurrence- more so in large sized weakness. A newer mesh appears to offer benefit over conventional meshes as it grips the tissues around the weakness without requiring staples or glue to fix it in place, and has shown to cause lesser post-operative pain and recurrence. This study is going to compare the newer self-gripping mesh with the conventional mesh requiring fixation to see which is best for patients undergoing keyhole repair to fix inguinal hernias.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 22, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 27, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 27, 2019

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

January 9, 2024

Status Verified

January 1, 2024

Enrollment Period

7.3 years

First QC Date

January 27, 2019

Last Update Submit

January 8, 2024

Conditions

Keywords

Inguinal herniaGroin herniaLaparoscopyMesh

Outcome Measures

Primary Outcomes (2)

  • Chronic pain rates Hernia recurrence rates

    Pain persisting beyond 3 months post inguinal hernia surgery

    12 months

  • Hernia recurrence rates

    Clinical or radiological evidence of inguinal hernia at any time point

    12 months

Secondary Outcomes (7)

  • Technical success

    1 day

  • Operative time

    1 day

  • Analgesia requirement

    1 week

  • Perioperative complications including injury to organs, bleeding

    1 day

  • Return to work and routine activities

    12 months

  • +2 more secondary outcomes

Study Arms (2)

Group 1 (Self-gripping Mesh),

ACTIVE COMPARATOR

The initial laparoscopic approach will be the same for both groups until the process of selection and placement of the mesh , which would be decided by randomization by sealed envelope. This group will receive self-gripping mesh

Device: self-gripping mesh

Group 2 (Stapled Mesh)

ACTIVE COMPARATOR

The initial laparoscopic approach will be the same for both groups until the process of selection and placement of the mesh , which would be decided by randomization by sealed envelope. This group will receive stapled mesh

Device: Stapled mesh

Interventions

The initial laparoscopic approach will be the same for both groups until the process of selection and placement of the mesh (ProGripTM self-gripping mesh versus standard 'lightweight' (large pore) polypropylene mesh fixed with SecurestrapTM) which would be decided by randomization by sealed envelope into one of the 2 intervention groups: Group 1 (Self-gripping Mesh), Group 2 (Stapled Mesh).

Group 1 (Self-gripping Mesh),

The initial laparoscopic approach will be the same for both groups until the process of selection and placement of the mesh (ProGripTM self-gripping mesh versus standard 'lightweight' (large pore) polypropylene mesh fixed with SecurestrapTM) which would be decided by randomization by sealed envelope into one of the 2 intervention groups: Group 1 (Self-gripping Mesh), Group 2 (Stapled Mesh).

Group 2 (Stapled Mesh)

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18
  • Demonstrated to have primary or recurrent unilateral or bilateral inguinal hernia
  • Both patient and surgeon occupy a position of equipoise over the relative merits of either intervention
  • Ability to give informed written consent

You may not qualify if:

  • Non-elective acute presentation with inguinal hernia and its complications
  • Inability to give informed written consent
  • Groin symptoms which on clinical examination and radiological investigations fail to demonstrate any evidence of inguinal hernia.
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Doncaster and Bassetlaw Teaching Hospitals Nhs Foundation Trust

Doncaster, South Yorkshire, DN2 5LT, United Kingdom

RECRUITING

MeSH Terms

Conditions

Hernia, Inguinal

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Srinivasan Balchandra, MS, MD, FRCS

    Doncaster and Bassetlaw Teaching Hospitals NHS Foundation trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Srinivasan Balchandra, MS, MD, FRCS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients will be unaware of the type of mesh received as the randomisation process will be carried out intraoperatively when the patient is under general anaesthesia. Subsequently, over the follow-up period every possible effort will be made to continue the blinding process in order to minimise any bias in patient reported outcomes. Similarly outcome assessors would be blinded as well.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a double blinded randomised controlled trial of ProGripTM self-gripping mesh versus standard 'lightweight' (large pore) polypropylene mesh fixed with SecurestrapTM an absorbable strap fixation device in the laparoscopic treatment of inguinal hernias. Sample size is 47 patients per group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 27, 2019

First Posted

February 27, 2019

Study Start

September 22, 2017

Primary Completion

December 31, 2024

Study Completion

May 31, 2025

Last Updated

January 9, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

The data will be utilised by the parent research team to make comparisons of the two techniques as listed in the protocol and results presented at scientific conferences and shared in the scientific literature. However sharing individual patient data has not been decided and in the future may be considered subject to data protection and confidentiality policies.

Shared Documents
STUDY PROTOCOL
Time Frame
6 months after the Trial completion and will be available for 2 years
Access Criteria
The study results will be shared with other researchers once completed. All listed and relevant participant Data, access criteria, statistics and clinical study report will be shared.

Locations